Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...
Meghan Markle recently unveiled her rebranded lifestyle brand, As Ever, and its new logo is packed with subtle nods to her family and personal history. The design features a palm tree encased by ...
The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...
Just like the brand’s logo, the brand’s name is full of meaning, too. In an Instagram video, Meghan explained, “As Ever essentially means ‘as it’s always been,’ and if you’ve ...
Meghan's forthcoming lifestyle brand, As Ever, replaces American Riviera Orchard, and its logo features some symbolic details – one of which could be a tribute to Prince Harry's late grandmother ...
It also partnered up with Invetx in January and advanced its ABS-101 drug and has plans to submit an Investigational New Drug application in Q1 2025. The consensus price target of $8.57 implies ...
Cutting corners: Researchers at Imperial College London say an artificial intelligence-based science tool created by Google needed just 48 hours to solve a problem that took them roughly a decade ...
It also partnered up with Invetx in January and advanced its ABS-101 drug and has plans to submit an Investigational New Drug application in Q1 2025. The consensus price target of $8.57 implies ...
Hosted on MSN19d
AbCellera Biologics (ABCL) Q4 2024 Earnings Call TranscriptThe investments in PP&E were partially offset by government contributions and the cash proceeds from the sale of our stake in Invetx during the year. We expect our PP&E investments to continue in ...
Good afternoon, and welcome to AbCellera's full-year 2024 business update conference call. My name is Tamia, and I will facilitate the audio portion of today's interactive broadcast. [Operator ...
and BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based therapeutics for animal health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results